摘要
目的 讨论及研究阿托伐他汀与曲美他嗪联合治疗冠心病的效果，明确药学内容。方法 以2024年1月-2024年12月收治的100例患者参与研究，通过随机进行分组，对照组和实验组，每组：50例，对照组：曲美他嗪治疗，实验组：阿托伐他汀联合曲美他嗪治疗，对比：治疗效果；血脂指标心功能指标。结果 两组患者通过不同的治疗方案后，实验组患者的治疗效果优于对照组，p<0.05，对比患者的血脂指标，实验组患者血脂指标优于对照组，p<0.05，评估患者心功能指标，实验组优于对照组，p<0.05。结论 对冠心病的患者提供阿托伐他汀联合曲美他嗪治疗，提升治疗效果，改善血脂、改善心功能，提升恢复速度。
关键词： 阿托伐他汀；曲美他嗪；冠心病；临床疗效；药学
Abstract
Objective To discuss and study the effect of atorvastatin combined with trimetazidine in the treatment of coronary heart disease and clarify the pharmaceutical content. Methods A total of 100 patients admitted from January 2024 to December 2024 participated in the study and were randomly divided into a control group and an experimental group, with 50 cases in each group. The control group was treated with trimetazidine, and the experimental group was treated with atorvastatin combined with trimetazidine. The comparison was as follows: treatment effect; blood lipid index and cardiac function index. Results After the two groups of patients were treated with different schemes, the treatment effect of the experimental group was better than that of the control group, p<0.05. The blood lipid index of the patients was compared, and the blood lipid index of the experimental group was better than that of the control group, p<0.05. The cardiac function index of the patients was evaluated, and the experimental group was better than the control group, p<0.05. Conclusion Providing atorvastatin combined with trimetazidine to patients with coronary heart disease can improve the treatment effect, improve blood lipids, improve heart function, and increase recovery speed.
Key words： Atorvastatin; Trimetazidine; Coronary heart disease; Clinical efficacy; Pharmacy
参考文献 References
[1] 任瑞巧.阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效及药学分析[J].中文科技期刊数据库（文摘版）医药卫生,2025(1):019-022.
[2] 苏少强,张晶晶.阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效及药学分析[J].北方药学,2024,21(4):61-63.
[3] 史玉娜.阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效观测[J].中文科技期刊数据库（引文版）医药卫生,2025(1): 050-053.
[4] Lauritzen T ,Munkhaugen J ,Bergan S , et al.Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart disease.[J].Clinical and translational science,2024,17 (10): e70025.
[5] 焦会仙.阿托伐他汀联合曲美他嗪治疗冠心病的显效率和总有效率分析[J].中文科技期刊数据库(文摘版)医药卫生,2025(2):118-121.
[6] 王恒永.瑞舒伐他汀联合曲美他嗪治疗冠心病稳定型心绞痛患者的临床效果[J].医药前沿,2025,15(3):51-54.
[7] 侯雨蒙,曹军.冠心病治疗中采用阿托伐他汀联合曲美他嗪治疗的临床疗效观察[J].中文科技期刊数据库（文摘版）医药卫生,2024(7):0029-0032.
[8] Hong J S ,Lee J Y ,Kang C W , et al.Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial[J].Cardiovascular Diabetology,2024, 23(1): 287-287.
[9] 王丽,李振.阿托伐他汀联合曲美他嗪治疗冠心病患者的临床效果及对其心功能的影响分析[J].中国现代药物应用,2024,18(8):91-94.
[10] Mingli C ,Fangfang M ,Baohua S , et al.Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients [J]. Medicine,2022,101(41):e31107-e31107.
[11] 石再丽.阿托伐他汀联合曲美他嗪对冠心病患者心绞痛症状的控制作用[J].中文科技期刊数据库(文摘版)医药卫生,2025(3):103-106.